Related references
Note: Only part of the references are listed.Evolution of OGTT in patients with β-thalassaemia major in relation to chelation therapy
Athanasios Christoforidis et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Serum zinc level and coronary heart disease events in patients with type 2 diabetes
Minna Soinio et al.
DIABETES CARE (2007)
Heme iron from diet as a risk factor for coronary heart disease in women with type 2 diabetes
Lu Qi et al.
DIABETES CARE (2007)
Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats
Deming Gong et al.
MOLECULAR PHARMACOLOGY (2006)
Combined chelation therapy improves glucose metabolism in patients with β-thalassaemia major
Athanasios Christoforidis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy
Lu Cai
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major
Kalistheni Farmaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Iron intake and the risk of type 2 diabetes in women - A prospective cohort study
Swapnil Rajpathak et al.
DIABETES CARE (2006)
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti et al.
BLOOD (2006)
Association between serum ferritin and the insulin resistance syndrome in a representative population
CE Wrede et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion
TYY Lai et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation
JX Wang et al.
CIRCULATION (2006)
Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of defemprone, deferoxampne, ICL670, GT56-252, L1NAII and starch deferoxamine polymers
George J. Kontoghiorghes
HEMOGLOBIN (2006)
Copper in medicine: Homeostasis, chelation therapy and antitumor drug design
T Wang et al.
CURRENT MEDICINAL CHEMISTRY (2006)
A copper chelating agent suppresses carbonyl stress in diabetic rat lenses
Y Hamada et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
Iron stores, blood donation, and insulin sensitivity and secretion
JM Fernández-Real et al.
CLINICAL CHEMISTRY (2005)
Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C
RFC D'Souza et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NAll and their combinations
GJ Kontoghiorghes et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Essentiality, toxicology and chelation therapy of zinc and copper
L Cai et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus
WL Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2004)
Regeneration of the heart in diabetes by selective copper chelation
GJS Cooper et al.
DIABETES (2004)
Potential role of increased iron stores in diabetes
JG Wilson et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2003)
Blood letting in high-ferritin type 2 diabetes -: Effects on insulin sensitivity and β-cell function
JM Fernández-Real et al.
DIABETES (2002)
Drinking water composition and childhood-onset Type 1 diabetes mellitus in Devon and Cornwall, England
HX Zhao et al.
DIABETIC MEDICINE (2001)
Beneficial effect of supplementation with copper sulfate on STZ-diabetic mice (IDDM)
S Sitasawad et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2001)
A syndrome of molybdenosis, copper deficiency, and type 2 diabetes in the moose population of south-west Sweden
A Frank et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2000)
Zinc as a paracrine effector in pancreatic islet cell death
BJ Kim et al.
DIABETES (2000)
Share Paper
